ARX:ASX
Aroa Biosurgery Ltd
A$ ०.४९
arrow_downward
-२.००%(-०.०१००) 1D
सेप्टेम्बर २९, १६:००:०० GMT+१० · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.४९
High
A$ ०.५०
Low
A$ ०.४९
Mkt. cap
१६.९५ करोड
Avg. vol.
१.२९ लाख
Volume
२.०३ लाख
P/E ratio
४७.१६
52-wk high
A$ ०.८०
52-wk low
A$ ०.४९
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.४९
High
A$ ०.५०
Low
A$ ०.४९
Mkt. cap
१६.९५ करोड
Avg. vol.
१.२९ लाख
Volume
२.०३ लाख
P/E ratio
४७.१६
52-wk high
A$ ०.८०
52-wk low
A$ ०.४९
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
TipRanks
·
१९ घण्टा पहिले
Aroa Biosurgery to Brief Investors on Interim MASTRR Registry Findings
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd